Promising Therapeutic Approach against COPD
DZL-Researchers have now succeeded in curing COPD in mice. Their goal is to test the novel therapeutic approach in human clinical trials over the next few years.
Menu
close
DZL-Researchers have now succeeded in curing COPD in mice. Their goal is to test the novel therapeutic approach in human clinical trials over the next few years.
Children growing up on a farm have a lower risk of developing asthma than children not living on a farm. A group of researchers clarified how the children’s gut microbiome is involved in the protection...
Number of macrophages in tumor tissue enables prognosis of lung tumor progression.
Infection with the novel coronavirus SARS-CoV-2 follows a highly variable course. The immune system plays a decisive role.
Ursula Klingmüller was recognised for her outstanding scientific achievements by being elected as a Member of the European Molecular Biology Organisation (EMBO).
Work group of DZL researcher identifies target molecule for the treatment of chronic obstructive pulmonary disease (COPD).
Lung cancer is the leading cause of cancer death for both men and women and accounts for almost 28% of all cancer deaths worldwide.
In a new project, scientists at the German Center for Lung Research (DZL) investigate the impact of e-cigarette vapor on lung health. This interdisciplinary approach combines various projects of all five sites.
T-helper cells stimulate the building of lung cancer metastasis.
A top global priority is to find agents that can stop the severe course of COVID-19 infection and consequently increase the chances of patient survival as rapidly as possible.
Scientists from the Berlin Institute of Health (BIH), Charité and the Thorax Clinic at Heidelberg University Hospital, whose collaboration is taking place under the auspices of the German Center for Lung Research (DZL), have examined...
Founded in 2001, the CAPNETZ research network is an associated partner of the DZL and has recorded clinical data from over 13,000 patients with community-acquired pneumonia (CAP) so far.
